Cytochrome c oxidase defects of the human substantia nigra in normal aging

Neurobiology of Aging

Volumn 17, Issue 6, 1996, Pages 843-848

  Itoh, Kyoko ^a   Weis, Serge ^a   Mehraein, Parviz ^a   Müller Höcker, Josef ^a  

^a UNIVERSITY OF MUNICH   (Germany)

Author keywords

cytochrome c oxidase (COX); human; immunohistochemistry; morphometry; normal aging; substantia nigra

Indexed keywords

CYTOCHROME C OXIDASE;

ADULT; AGED; AGING; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DOPAMINERGIC SYSTEM; ENZYME DEFICIENCY; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; MORPHOMETRICS; PHOSPHORYLATION; PRIORITY JOURNAL; RESPIRATORY CHAIN; SUBSTANTIA NIGRA;

ADULT; AGED; AGED, 80 AND OVER; AGING; CELL COUNT; DOPAMINE; ELECTRON TRANSPORT COMPLEX IV; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; NEURONS; OXIDATIVE PHOSPHORYLATION; SUBSTANTIA NIGRA;

EID: 0030294728     PISSN: 01974580     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0197-4580(96)00168-6     Document Type: Article

References (43)

1. 1. Cardellach, F.; Galofre, J.; Cusso, R.; Urbano-Marquez, A. Decline in skeletal muscle mitochondrial respiration chain function with aging. Lancet 7:44-45; 1989.
2. 2. Corral-Debrinski, M.; Horton, T.; Lott, M. T.; Shoffner, J. M.; Beal, M. F.; Wallace, D. C. Mitochondrial DNA deletions in human brain: Regional variability and increase with advanced age. Nat. Genet. 2: 324-329; 1992.
3. 3. Curti, D.; Giangare, M. C.; Redolfi, M. E.; Fugaccia, I.; Benzi, G. Age-related modification of cytochrome oxidase activity of synaptic and nonsynaptic mitochondria during aging. Mech. Ageing Dev. 55: 171-180; 1990.
4. 4. Date, I.; Felten, S. Y.; Olschowka, J. A.; Felten, D. L. Limited recovery of striatal dopaminergic fibers by adrenal medullary grafts in MPTP-treated aging mice. Exp. Neurol. 107:197-207; 1990.
5. 5. Date, I.; Notter, M. F. D.; Felten, S. Y.; Felten, D. L. MPTP-treated young mice but not aging mice show partial recovery of the nigrostriatal dopaminergic system by stereotaxic injection of acidic fibroblast growth factor (aFGF). Brain Res. 526:156-160; 1990.
6. 6. Date, I.; Felten, S. Y.; Felten, D. L. Exogenous GM1 gangliosides induce partial recovery of the nigrastriatal dopaminergic system in MPTP-treated young mice but not in aging mice. Neurosci. Lett. 106: 282-286; 1989.
7. 7. DiMauro, S.; Wallace, D. C. Mitochondrial DNA in human pathology. New York: Raven Press Ltd.; 1993.
8. 8. Evans, D. A.; Funckenstein, H. H.; Albert, M. S. Prevalence of Alzheimer's disease in a community population of older persons. Higher than previously reported. JAMA 262:2551-2556; 1989.
9. 9. Fearnley, J. M.; Lees, A. J. Aging and Parkinson's disease: Substantia nigra regional selectivity. Brain 114:2283-2301; 1991.
10. 10. Felton, D. L.; Felton, S. Y.; Fuller, R. W.; Romano, T. D.; Smalstig, E. B.; Wong, D. T.; Clemens, J. A. Chronic dietary pergolide preserves nigrostriatal neuronal integrity in aged Fischer 344 rats. Neurobiol. Aging 13:339-351; 1992.
11. 11. Felton, D. L.; Felton, S. Y.; Steece-Collier, K.; Date, I.; Clemens, J. A. Age-related decline in the dopaminergic nigrostriatal system: The oxidative hypothesis and protective strategies. Ann. Neurol. Suppl. 32: 133-132; 1992.
12. 12. Gibb, W. R. G.; Fearnley, J. M.; Lees, A. J. The anatomy and pigmentation of the human substantia nigra in relation to selective neuronal vulnerability. Adv. Neurol 53:31-34; 1990.
13. 13. Gundersen, H. J. G. Notes on the estimation of the numerical density of arbitrary profiles: The edge effects. J. Microsc. 111:219-223; 1977.
14. 14. Hattori, K.; Tanaka, M.; Sugiyama, S.; Obayashi, T.; Ito, T.; Satake, T.; Hanaki, Y.; Asai, Y.; Nagano, M.; Ozawa, T. Age-dependent increase in deleted mitochondrial DNA in the human heart: Possible contributory factor to presbycardia. Am. Heart J. 121:1735-1742; 1991.
15. 15. Hattori, Y.; Tanaka, M.; Ozawa, T.; Mizuno, Y. Immunohistochemical studies on complexes I, II, III, and IV of mitochondria in Parkinson's disease. Ann. Neurol. 30:563-571; 1991.
16. 16. Hirsch, E. C. Why are nigral catecholaminergic neurons more vulnerable than other cells in Parkinson's disease? Ann. Neurol. 32:S88-S93; 1992.
17. 17. Ichitani, Y.; Okamura, H.; Matsumoto, Y.; Nagatsu, I.; Ibata, Y. Degeneration of the nigral dopamine neurons after 6-hydroxydopamine injection into the rat striatum. Brain Res. 549:350-353; 1991.
18. 18. Jenner, P.; Dexter, D. T.; Sian, J.; Schapira, A. H. V.; Marsden, C. D. Oxidative stress as a cause of nigral cell death in Parkinson's disease and incidental Lewy body disease. Ann. Neurol. 32:S82-S87; 1992.
19. 19. Linnane, A. W.; Marzuki, S.; Ozawa, T.; Tanaka, M. Mitochondrial DNA mutations as an important contributor to aging and degenerative disease. Lancet 3:642-645; 1989.
20. 20. Mann, D. M. A.; Yates, P. O.; Marcyniuk, B. Monoaminergic neurotransmitter systems in presenile Alzheimer's disease and in senile dementia of Alzheimer type. Clin. Neuropathol. 3:199-205; 1984.
21. 21. Mann, V. M.; Cooper, J. M.; Javoy-Agid, F.; Agid, Y.; Jenner, P.; Schapira, A. H. V. Mitochondrial function and parental sex effect in Huntington's disease. Lancet 336:749; 1990.
22. 22. McGeer, P. L.; McGeer, E. G.; Suzuki, J. S. Aging and extrapyramidal function. Arch. Neurol. 34:33-35; 1977.
23. 23. Mecocci, P.; Garvey, U.; Kaufman, A. E.; Koontz, D.; Shoffner, J. M.; Wallace, D. C.; Beal, M. F. Oxidative damage to mitochondrial DNA shows marked age-dependent increase in human brain. Ann. Neurol. 34:609-616; 1993.
24. 24. Mita, S.; Schmidt, B.; Schon, E. A.; DiMauro, S.; Bonilla, E. Detection of "deleted" mitochondrial genomes in cytochrome-c-oxidase-deficient muscle fibers of a patient with Keams-Sayre syndrome. Proc. Natl. Acad. Sci. USA 86:9509-9513; 1989.
25. 25. Müller-Höcker, J. Cytochrome-c-oxidase deficient cardiomyocytes in the human heart. An age-related phenomenon. Am. J. Pathol. 134: 1167-1173; 1989.
26. 26. Müller-Höcker, J. Cytochrome-c-oxidase deficient fibers in the limb muscle and diaphragma of man without muscular disease: An age-related alteration. J. Neurol. Sci. 100:14-20; 1990.
27. 27. Müller-Höcker, J.; Seibel, P.; Schneiderbanger, K.; Ziets, C.; Obermaier-Kusser, B.; Gerbitz, K. D.; Kadenbach, B. In situ hybridization of mitochondrial DNA in the heart of a patient with Kearns-Sayre syndrome and dilative cardiomyopathy. Hum. Pathol. 23:1431-1437; 1992.
28. 28. Müller-Höcker, J.; Seibel, P.; Schneiderbanger, K.; Kadenbach, B. Different in situ hybridization patterns of mitochondrial DNA in cytochrome c oxidase-deficient extraocular muscle fibers in the elderly. Virchows Arch. A Pathol. Anat. 422:7-15; 1993.
29. 29. Münsche, C.; Müller-Höcker, J.; Kadenbach, B. Human aging is associated with various point mutations in tRNA gene of mitochondrial DNA. Biol. Chem. Hoppe-Seyler 374:1099-1104; 1993.
30. 30. Olszewski, J.; Baxter, D. Cytoarchitecture of the human brain stem. 2nd ed. Basel: Karger; 1982.
31. 31. Parker, W. D.; Mhr, N.J.; Filley, C. M.; Parks, J. K.; Hughes, D.; Young, D. A.; Cullum, C. M. Reduced platelet cytochrome c oxidase activity in Alzheimer's disease. Neurology 44:1086-1090; 1994.
32. 32. Parker, W. D.; Parks, J.; Filley, C. M.; Kleinschmidt-DeMasters, B. K. Electron transport chain defects in Alzheimer's disease brain. Neurology 44:1090-1096; 1994.
33. 33. Sabel, B. A.; Stein, D. G. Extensive loss of subcortical neurons in the aging rat brain. Exp. Neurol. 73:507-516; 1981.
34. 34. Schapira, A. H. V.; Mann, V. M.; Cooper, J. M.; Dexter, D.; Daniel, S. E.; Jenner, P.; Clark, J. B.; Marsden, C. D. Anatomic and disease specificity of NADH CoQ reductase (complex I) deficiency in Parkinson's disease. J. Neurochem. 55:2142-2145; 1990.
35. 35. Schapira, A. H. V.; Holt, I. J.; Sweeney, M.; Harding, A. E.; Jenner, P.; Marsden, C. D. Mitochondrial DNA analysis in Parkinson's disease. Movment Disord. 5:294-297; 1990.
36. 36. Schapira, A. H. V. Evidence for mitochondrial dysfunction in Parkinson's disease - A critical appraisal. Movement Disord. 1:125-138; 1994.
37. 37. Shoubridge, E. A.; Karpati, G.; Hastings, K. E. M. Deletion mutants are functionally dominant over wild-type mitochondrial genomes in skeletal muscle fibre segments in mitochondrial disease. Cell 62:43-49; 1990.
38. 38. Soong, N. W.; Hinton, D. R.; Cortopassi, G,; Arnheim, N. Mosaicism for a specific somatic mitochondrial DNA mutation in adult human brain. Nat. Genet. 2:318-323; 1992.
39. 39. Sugiyama, S.; Hattori, K.; Hayakawa, M.; Ozawa, T. Quantitative analysis of age-matched accumulation of mitochondrial DNA with deletion in human hearts. Biochem. Biophys. Res. Commun. 180:894-899; 1991.
40. 40. Trounce, I.; Byrne, E.; Marzuki, S. Decline in skeletal muscle mitochondiral respiratory chain function: Possible factor in aging. Lancet 3:637-639; 1989.
41. 41. van Domburg, P. H. M. F.; ten Donkelaar, H. J. The human substantia nigra and ventral tegmental area. Berlin: Springer Verlag; 1991.
42. 42. Weis, S. Morphometry in the neurosciences. In: Wenger, E.; Dimitrov, L., eds. Digital image processing and computer graphics. München, Wien: Oldenburg; 1991:306-325.
43. 43. Yen, T.-C.; Su, J.-H.; King, K.-L.; Wei, Y.-H. Ageing-associated 5 kb deletion in human liver mitochondrial DNA. Biochem. Biophys. Res. Commun. 178:124-131; 1991.